Bromosporine is a Potent BET Inhibitor for Hematologic Neoplasms Research
Abnormal gene transcription and constitutive activation of signaling pathways are major contributors to cancer development. Recent developments in cancer research have focused on targeting epigenetic regulators, such as the bromodomain…